medigraphic.com
ISSN 2078-7162 (Print)

2014, Number 2

<< Back Next >>

Rev Cub de Med Fis y Rehab 2014; 6 (2)

Influence of physical exercise on quality of life in patients with chronic obstructive pulmonary disease

García EA, Pedroso MI, Bravo AT, Pérez-Saad H, Pérez PEE

Language: Spanish
References: 34
Page: 126-137
PDF size: 335.51 Kb.


ABSTRACT

Introduction: chronic obstructive pulmonary disease (COPD), a generally irreversible disease, characterized by the existence of an obstruction of the airways, with marked decrease in respiratory capacity and progressive deterioration of the quality of life related to health (HRLQOL) of those affected. It has been invoked the utility of implementing physical rehabilitation programs in the treatment of patients.
Objective: to study the effect of a protocol of physical exercises developed at the Department of Rehabilitation of Center for Medical and Surgical Research in patients with COPD.
Methods: For three months, a sample of 50 COPD patients from the Department of Pneumology underwent a controlled and personalized program, of aerobics and calisthenics, walk test and bike exercise. The results were evaluated through a group of clinical and functional elements, anthropometric tests, measurements of respiratory function, and the FS-36 questionnaire.
Results: when starting parameters of the program were compared with the ending parameters, a significant improvement in clinical and functional elements were demonstrated, a significant improvement of skeletal muscle measurements, as well as in FEV1. The patients' responses to the questionnaire SF-36 showed a significant improvement in all dimensions contained therein.
Conclusions: the exercise program implemented as part of a comprehensive rehabilitation program had a positive effect on the morphofunctional condition of the patients, and a favorable impact on their quality of life.


REFERENCES

  1. Celli B, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.

  2. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000; 117(2 Suppl): 1S-4S.

  3. Petty T. Scope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and intervention. Chest 2000; 117(5 Suppl 2): 326S-31S.

  4. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Malken MP. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax. 2010;65(8):711-18.

  5. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials. Chest. 2010; 137(2):318-25.

  6. Shapiro SD, Reilly JJ Jr., Rennard SI. Chronic bronchitis and emphysema. In: Mason RJ, Broaddus VC, Martin TR, et al. Murray & Nadel's Textbook of Respiratory Medicine. 5th ed. Philadelphia, Pa: Saunders Elsevier; 2010:chap 39.

  7. Multi-Center Survey of COPD in Five Major Latin-American Cities: the "PLATINO" Surve. Proposal by Ana Menezes (presentado por ALAT Boehringer-Ingelheim). Pelotas, 2002. .

  8. Menezes A, Victora C, Pérez-Padilla R, The PLATINO Team. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. [artículo en línea]. BMC Med Res Methodol 2004; 4(1):15

  9. National Heart, Lung, and Blood Institute. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda: WHO, 2001.

  10. Pena V, Miravitlles M, Gabriel R, Jimenez-Ruiz C, Villasante C, Masa J, et al. Geographic variations in prevalence and underdiagnosis of COPD: result of the IBERCOP multicenter epidemiological study. Chest 2000; 118: 981-9

  11. Nici L, Donner C, Wouter E, Zumallack R,Ambrostina N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-413.

  12. Pauwels R, Buist A, Calverley P, Jenkins C R, Hurds S, et al. Global Strategy for the Diagnosis Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76.

  13. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J Eur Respir J 2004; 23: 932-46.

  14. Troosters T, Casaburi R, Gosselink R, Decmamer M, et al. Pulmonary Rehabiliatation in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2005; 172: 19-38.

  15. Salman G, Mosier M, Beasley B, Calkins, et al. Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease. Meta-analysis of Randomized Controlled Trials. J Gen Intern Med 2003; 18: 213-21.

  16. British Thoracic Society. Standards of Care Subcommittee on Pulmonary Rehabilitation. Thorax 2001; 56: 827-34.

  17. American Thoracic Society. Dyspnea Mechanisms, Assessment, and Management: A Consensus Statement. Am J Respir Crit Care Med 1999; 159: 321-40.

  18. Robinson Ramírez Vélez. Calidad de vida en enfermedad pulmonar obstructiva crónica. Revista Ciencias de la Salud. Universidad del rosario. 2007: Vol. 5, pp. 90- 100.

  19. Carone M.ç, Jones PW. Health status “quality of life”. En: Pulmonary Rehabilitation. Donner C y Decramer M. eds. Eur Respir Mon 2000, 5, 22-35.

  20. European Community Respiratory Health Survey. ECRCHS2 II [Consultado 10 ago 2004]

  21. Rodriguez-Roisin R. Global Initiative for Chronic Obstructive Lung Disease (GOLD) writing group. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2008. Accessed July 30, 2009.

  22. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278: 1355-60.

  23. Cosio MG, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J et al. The relations between structural changes in small airways and pulmonary function tests. N Engl J Med 1978; 298: 1277-81.

  24. Filkenstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152: 1666-72.

  25. Solanes I, Güell R, Casan P, et al. Duration of pulmonary rehabilitation to achieve a plateau in quality of life and walk test in COPD. Respir Med. 2009;103(5):722–28.

  26. Bourbeau J, Maltais F, Rouleau M, Guimont C: French-Canadian version of the Chronic Respiratory and St George’s Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J 2004, 11:480-486.

  27. Bourbeau J, Maltais F, Rouleau M, Guimont C: French-Canadian version of the Chronic Respiratory and St George’s Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J 2004, 11:480-486.

  28. Blinderman CD, Homel P, Billings JA, Teenstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage. 2009; 38:115–123.

  29. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131 (Suppl 5):S4–S42.

  30. Spencer LM, Alison JA, and McKeough Zoe J. Do supervised weekly exercise programs maintain functional exercise capacity and quality of life, twelve months after pulmonary rehabilitation in COPD. BMC Pulmonary Medicine 2007, 7:7 doi: 10.1186/1471-2466-7-7.

  31. Fermoselle C, Rabinovich R, Ausin P, Puig-Vilanova E, Coronell C, Sanchez F, et-al. Does oxidative stress modulate limb muscle atrophy in severe copd patients? [en prensa]. Eur Respir J. 2012.

  32. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys Dec; 2007 43(4): 475–485. [PubMed: 18084170.

  33. Tuesca R. La calidad de vida, su importancia y como medirla. Salud Uninorte, Universidad del Norte Barranquilla, Colombia, 21: Jul-Dic, pp.76-86. 2005.

  34. National Heart, Lung, and Blood Institute. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive disease. Bethesda: WHO, 2001.




2020     |     www.medigraphic.com